HEADER CHAPERONE 28-NOV-15 5FPD TITLE STRUCTURE OF HEAT SHOCK-RELATED 70KDA PROTEIN 2 WITH SMALL-MOLECULE TITLE 2 LIGAND PYRAZINE-2-CARBOXAMIDE (AT513) IN AN ALTERNATE BINDING SITE. COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEAT SHOCK-RELATED 70KDA PROTEIN 2; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET28B KEYWDS HEAT SHOCK-RELATED PROTEIN, HEAT SHOCK, CHAPERONE, HSP70, HSPA2, KEYWDS 2 PROTEIN-LIGAND COMPLEX, FRAGMENT SCREENING, ALTERNATE BINDING SITE, KEYWDS 3 AT513. EXPDTA X-RAY DIFFRACTION AUTHOR H.JHOTI,R.F.LUDLOW,S.PATEL,H.K.SAINI,I.J.TICKLE,M.VERDONK REVDAT 5 10-JAN-24 5FPD 1 REMARK REVDAT 4 06-APR-16 5FPD 1 HETSYN HETATM CONECT REVDAT 3 13-JAN-16 5FPD 1 JRNL REVDAT 2 23-DEC-15 5FPD 1 JRNL REVDAT 1 16-DEC-15 5FPD 0 JRNL AUTH R.F.LUDLOW,M.L.VERDONK,H.K.SAINI,I.J.TICKLE,H.JHOTI JRNL TITL DETECTION OF SECONDARY BINDING SITES IN PROTEINS USING JRNL TITL 2 FRAGMENT SCREENING. JRNL REF PROC.NATL.ACAD.SCI.USA V. 112 15910 2015 JRNL REFN ISSN 0027-8424 JRNL PMID 26655740 JRNL DOI 10.1073/PNAS.1518946112 REMARK 2 REMARK 2 RESOLUTION. 1.97 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.97 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.34 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 3 NUMBER OF REFLECTIONS : 51667 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.173 REMARK 3 R VALUE (WORKING SET) : 0.170 REMARK 3 FREE R VALUE : 0.223 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.110 REMARK 3 FREE R VALUE TEST SET COUNT : 2638 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.97 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 87.18 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3393 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1646 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3235 REMARK 3 BIN R VALUE (WORKING SET) : 0.1601 REMARK 3 BIN FREE R VALUE : 0.2582 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.66 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 158 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5775 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 18 REMARK 3 SOLVENT ATOMS : 878 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.79 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.45 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.50500 REMARK 3 B22 (A**2) : 1.32810 REMARK 3 B33 (A**2) : -1.83310 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.06430 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.918 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 5894 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 7963 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2078 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 157 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 888 ; 16.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 5894 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 802 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 7654 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 BOND ANGLES (DEGREES) : 1.01 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 5.51 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.66 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 6 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|4 - A|188 A|368 - A|384 } REMARK 3 ORIGIN FOR THE GROUP (A): 27.6088 -9.2205 2.7557 REMARK 3 T TENSOR REMARK 3 T11: -0.0333 T22: -0.0416 REMARK 3 T33: -0.0356 T12: 0.0145 REMARK 3 T13: 0.0025 T23: -0.0057 REMARK 3 L TENSOR REMARK 3 L11: 1.2116 L22: 0.7544 REMARK 3 L33: 0.6760 L12: 0.0016 REMARK 3 L13: 0.1548 L23: -0.1606 REMARK 3 S TENSOR REMARK 3 S11: -0.0287 S12: -0.0523 S13: -0.0053 REMARK 3 S21: 0.0123 S22: 0.0045 S23: -0.0365 REMARK 3 S31: 0.0333 S32: 0.0208 S33: 0.0242 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { A|192 - A|231 A|309 - A|367 } REMARK 3 ORIGIN FOR THE GROUP (A): 15.4594 8.4589 -8.0477 REMARK 3 T TENSOR REMARK 3 T11: -0.0186 T22: -0.0397 REMARK 3 T33: -0.0020 T12: 0.0065 REMARK 3 T13: -0.0285 T23: 0.0205 REMARK 3 L TENSOR REMARK 3 L11: 0.8168 L22: 1.1561 REMARK 3 L33: 1.3330 L12: 0.1315 REMARK 3 L13: 0.4424 L23: 0.1172 REMARK 3 S TENSOR REMARK 3 S11: -0.0323 S12: 0.1037 S13: 0.1181 REMARK 3 S21: -0.1045 S22: 0.0053 S23: 0.0507 REMARK 3 S31: -0.0339 S32: -0.0198 S33: 0.0270 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: { A|232 - A|308 } REMARK 3 ORIGIN FOR THE GROUP (A): 25.1139 16.2273 19.1195 REMARK 3 T TENSOR REMARK 3 T11: -0.0184 T22: -0.0487 REMARK 3 T33: -0.0185 T12: 0.0186 REMARK 3 T13: -0.0019 T23: -0.0021 REMARK 3 L TENSOR REMARK 3 L11: 2.8780 L22: 0.5933 REMARK 3 L33: 2.0280 L12: -0.4684 REMARK 3 L13: 1.6145 L23: -0.0369 REMARK 3 S TENSOR REMARK 3 S11: -0.1731 S12: -0.2511 S13: 0.1600 REMARK 3 S21: 0.0566 S22: -0.0176 S23: 0.0606 REMARK 3 S31: -0.0893 S32: -0.1218 S33: 0.1906 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: { B|4 - B|188 B|368 - B|384 } REMARK 3 ORIGIN FOR THE GROUP (A): 51.9828 0.0133 38.1633 REMARK 3 T TENSOR REMARK 3 T11: -0.0280 T22: -0.0427 REMARK 3 T33: -0.0373 T12: -0.0147 REMARK 3 T13: 0.0118 T23: -0.0059 REMARK 3 L TENSOR REMARK 3 L11: 1.2181 L22: 0.7470 REMARK 3 L33: 0.6768 L12: 0.0375 REMARK 3 L13: -0.1825 L23: -0.1744 REMARK 3 S TENSOR REMARK 3 S11: -0.0270 S12: 0.0663 S13: -0.0053 REMARK 3 S21: -0.0121 S22: -0.0001 S23: -0.0435 REMARK 3 S31: -0.0411 S32: 0.0254 S33: 0.0272 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 SELECTION: { B|192 - B|231 B|309 - B|367 } REMARK 3 ORIGIN FOR THE GROUP (A): 39.8902 -17.7668 48.8735 REMARK 3 T TENSOR REMARK 3 T11: -0.0187 T22: -0.0438 REMARK 3 T33: -0.0021 T12: -0.0091 REMARK 3 T13: 0.0396 T23: 0.0157 REMARK 3 L TENSOR REMARK 3 L11: 0.7948 L22: 1.0292 REMARK 3 L33: 1.3372 L12: -0.2344 REMARK 3 L13: -0.5044 L23: 0.1366 REMARK 3 S TENSOR REMARK 3 S11: -0.0404 S12: -0.0899 S13: -0.1278 REMARK 3 S21: 0.1335 S22: 0.0280 S23: 0.0787 REMARK 3 S31: 0.0414 S32: -0.0130 S33: 0.0124 REMARK 3 REMARK 3 TLS GROUP : 6 REMARK 3 SELECTION: { B|232 - B|308 } REMARK 3 ORIGIN FOR THE GROUP (A): 49.5102 -25.4952 21.7049 REMARK 3 T TENSOR REMARK 3 T11: -0.0211 T22: -0.0418 REMARK 3 T33: -0.0226 T12: -0.0187 REMARK 3 T13: 0.0112 T23: -0.0026 REMARK 3 L TENSOR REMARK 3 L11: 2.8577 L22: 0.8298 REMARK 3 L33: 1.8535 L12: 0.6370 REMARK 3 L13: -1.4326 L23: -0.2516 REMARK 3 S TENSOR REMARK 3 S11: -0.1559 S12: 0.2812 S13: -0.1026 REMARK 3 S21: -0.0496 S22: -0.0047 S23: 0.0291 REMARK 3 S31: 0.1224 S32: -0.1093 S33: 0.1606 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5FPD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-NOV-15. REMARK 100 THE DEPOSITION ID IS D_1290065658. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-MAY-08 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 53188 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.970 REMARK 200 RESOLUTION RANGE LOW (A) : 38.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.700 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.97 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.03 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.16000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1S3X REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.0M NACL, 0.1M TRIS/HCL PH=8, 20.0% REMARK 280 W/V PEG 8000. PROTEIN CONC. = 9MG/ML., PH 8 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 47.53100 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -3 REMARK 465 SER A -2 REMARK 465 HIS A -1 REMARK 465 MET A 0 REMARK 465 ARG A 3 REMARK 465 GLY A 189 REMARK 465 CYS A 190 REMARK 465 ALA A 191 REMARK 465 ASP A 385 REMARK 465 GLY B -3 REMARK 465 SER B -2 REMARK 465 HIS B -1 REMARK 465 MET B 0 REMARK 465 ARG B 3 REMARK 465 GLY B 189 REMARK 465 CYS B 190 REMARK 465 ALA B 191 REMARK 465 ASP B 385 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 25 CD CE NZ REMARK 470 LYS A 77 CE NZ REMARK 470 LYS A 88 CE NZ REMARK 470 LYS A 100 CE NZ REMARK 470 LYS A 195 CD CE NZ REMARK 470 LYS A 222 CE NZ REMARK 470 LYS A 252 CD CE NZ REMARK 470 GLU A 317 CD OE1 OE2 REMARK 470 LYS A 321 CE NZ REMARK 470 LYS A 350 CE NZ REMARK 470 GLY A 384 C O REMARK 470 GLY B 4 N REMARK 470 LYS B 25 CG CD CE NZ REMARK 470 LYS B 88 CE NZ REMARK 470 LYS B 100 CE NZ REMARK 470 LYS B 112 CE NZ REMARK 470 LYS B 187 NZ REMARK 470 GLY B 192 N CA REMARK 470 LYS B 222 CE NZ REMARK 470 LYS B 248 NZ REMARK 470 LYS B 252 CG CD CE NZ REMARK 470 ARG B 274 CD NE CZ NH1 NH2 REMARK 470 LYS B 321 CE NZ REMARK 470 GLU B 360 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 366 117.74 -39.86 REMARK 500 ARG B 171 147.58 -170.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2214 DISTANCE = 5.95 ANGSTROMS REMARK 525 HOH B2028 DISTANCE = 5.82 ANGSTROMS REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 PYRAZINE-2-CARBOXAMIDE (L02): ASTEX COMPOUND REGISTRY REMARK 600 AT513. REMARK 600 PYRAZINE-2-CARBOXAMIDE (L01): ASTEX COMPOUND REGISTRY REMARK 600 AT513. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PZA A 1385 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PZA B 1385 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5FP5 RELATED DB: PDB REMARK 900 STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH SMALL- MOLECULE LIGAND REMARK 900 4-FLUOROBENZOIC ACID (AT222) IN AN ALTERNATE BINDING SITE. REMARK 900 RELATED ID: 5FP6 RELATED DB: PDB REMARK 900 STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH SMALL- MOLECULE LIGAND REMARK 900 3-(4,7-DICHLORO-1H-INDOL-3-YL)PROP -2-YN-1-OL (AT17833) IN AN REMARK 900 ALTERNATE BINDING SITE. REMARK 900 RELATED ID: 5FPE RELATED DB: PDB REMARK 900 STRUCTURE OF HEAT SHOCK-RELATED 70KDA PROTEIN 2 WITH SMALL-MOLECULE REMARK 900 LIGAND 1H-1,2,4-TRIAZOL-3-AMINE ( AT485) IN AN ALTERNATE BINDING REMARK 900 SITE. REMARK 900 RELATED ID: 5FPM RELATED DB: PDB REMARK 900 STRUCTURE OF HEAT SHOCK-RELATED 70KDA PROTEIN 2 WITH SMALL-MOLECULE REMARK 900 LIGAND 5-PHENYL-1,3,4-OXADIAZOLE-2- THIOL (AT809) IN AN ALTERNATE REMARK 900 BINDING SITE. REMARK 900 RELATED ID: 5FPN RELATED DB: PDB REMARK 900 STRUCTURE OF HEAT SHOCK-RELATED 70KDA PROTEIN 2 WITH SMALL-MOLECULE REMARK 900 LIGAND 3,5-DIMETHYL-1H-PYRAZOLE-4- CARBOXYLIC ACID (AT9084) IN AN REMARK 900 ALTERNATE BINDING SITE. REMARK 900 RELATED ID: 5FPO RELATED DB: PDB REMARK 900 STRUCTURE OF BACTERIAL DNA LIGASE WITH SMALL-MOLECULE LIGAND 1H- REMARK 900 INDAZOL-7-AMINE (AT4213) IN AN ALTERNATE BINDING SITE. REMARK 900 RELATED ID: 5FPR RELATED DB: PDB REMARK 900 STRUCTURE OF BACTERIAL DNA LIGASE WITH SMALL-MOLECULE LIGAND REMARK 900 PYRIMIDIN-2-AMINE (AT371) IN AN ALTERNATE BINDING SITE. REMARK 900 RELATED ID: 5FPS RELATED DB: PDB REMARK 900 STRUCTURE OF HEPATITIS C VIRUS (HCV) FULL-LENGTH NS3 COMPLEX WITH REMARK 900 SMALL-MOLECULE LIGAND 3-AMINOBENZENE-1,2 -DICARBOXYLIC ACID (AT1246) REMARK 900 IN AN ALTERNATE BINDING SITE. REMARK 900 RELATED ID: 5FPT RELATED DB: PDB REMARK 900 STRUCTURE OF HEPATITIS C VIRUS (HCV) FULL-LENGTH NS3 COMPLEX WITH REMARK 900 SMALL-MOLECULE LIGAND 2-(1-METHYL-1H- INDOL-3-YL)ACETIC ACID REMARK 900 (AT3437) IN AN ALTERNATE BINDING SITE. REMARK 900 RELATED ID: 5FPY RELATED DB: PDB REMARK 900 STRUCTURE OF HEPATITIS C VIRUS (HCV) FULL-LENGTH NS3 COMPLEX WITH REMARK 900 SMALL-MOLECULE LIGAND 5-BROMO-1-METHYL- 1H-INDOLE-2-CARBOXYLIC ACID REMARK 900 (AT21457) IN AN ALTERNATE BINDING SITE. DBREF 5FPD A 0 385 UNP P54652 HSP72_HUMAN 1 386 DBREF 5FPD B 0 385 UNP P54652 HSP72_HUMAN 1 386 SEQADV 5FPD GLY A -3 UNP P54652 EXPRESSION TAG SEQADV 5FPD SER A -2 UNP P54652 EXPRESSION TAG SEQADV 5FPD HIS A -1 UNP P54652 EXPRESSION TAG SEQADV 5FPD A UNP P54652 SER 2 DELETION SEQADV 5FPD A UNP P54652 ALA 3 DELETION SEQADV 5FPD GLY B -3 UNP P54652 EXPRESSION TAG SEQADV 5FPD SER B -2 UNP P54652 EXPRESSION TAG SEQADV 5FPD HIS B -1 UNP P54652 EXPRESSION TAG SEQADV 5FPD B UNP P54652 SER 2 DELETION SEQADV 5FPD B UNP P54652 ALA 3 DELETION SEQRES 1 A 387 GLY SER HIS MET ARG GLY PRO ALA ILE GLY ILE ASP LEU SEQRES 2 A 387 GLY THR THR TYR SER CYS VAL GLY VAL PHE GLN HIS GLY SEQRES 3 A 387 LYS VAL GLU ILE ILE ALA ASN ASP GLN GLY ASN ARG THR SEQRES 4 A 387 THR PRO SER TYR VAL ALA PHE THR ASP THR GLU ARG LEU SEQRES 5 A 387 ILE GLY ASP ALA ALA LYS ASN GLN VAL ALA MET ASN PRO SEQRES 6 A 387 THR ASN THR ILE PHE ASP ALA LYS ARG LEU ILE GLY ARG SEQRES 7 A 387 LYS PHE GLU ASP ALA THR VAL GLN SER ASP MET LYS HIS SEQRES 8 A 387 TRP PRO PHE ARG VAL VAL SER GLU GLY GLY LYS PRO LYS SEQRES 9 A 387 VAL GLN VAL GLU TYR LYS GLY GLU THR LYS THR PHE PHE SEQRES 10 A 387 PRO GLU GLU ILE SER SER MET VAL LEU THR LYS MET LYS SEQRES 11 A 387 GLU ILE ALA GLU ALA TYR LEU GLY GLY LYS VAL HIS SER SEQRES 12 A 387 ALA VAL ILE THR VAL PRO ALA TYR PHE ASN ASP SER GLN SEQRES 13 A 387 ARG GLN ALA THR LYS ASP ALA GLY THR ILE THR GLY LEU SEQRES 14 A 387 ASN VAL LEU ARG ILE ILE ASN GLU PRO THR ALA ALA ALA SEQRES 15 A 387 ILE ALA TYR GLY LEU ASP LYS LYS GLY CYS ALA GLY GLY SEQRES 16 A 387 GLU LYS ASN VAL LEU ILE PHE ASP LEU GLY GLY GLY THR SEQRES 17 A 387 PHE ASP VAL SER ILE LEU THR ILE GLU ASP GLY ILE PHE SEQRES 18 A 387 GLU VAL LYS SER THR ALA GLY ASP THR HIS LEU GLY GLY SEQRES 19 A 387 GLU ASP PHE ASP ASN ARG MET VAL SER HIS LEU ALA GLU SEQRES 20 A 387 GLU PHE LYS ARG LYS HIS LYS LYS ASP ILE GLY PRO ASN SEQRES 21 A 387 LYS ARG ALA VAL ARG ARG LEU ARG THR ALA CYS GLU ARG SEQRES 22 A 387 ALA LYS ARG THR LEU SER SER SER THR GLN ALA SER ILE SEQRES 23 A 387 GLU ILE ASP SER LEU TYR GLU GLY VAL ASP PHE TYR THR SEQRES 24 A 387 SER ILE THR ARG ALA ARG PHE GLU GLU LEU ASN ALA ASP SEQRES 25 A 387 LEU PHE ARG GLY THR LEU GLU PRO VAL GLU LYS ALA LEU SEQRES 26 A 387 ARG ASP ALA LYS LEU ASP LYS GLY GLN ILE GLN GLU ILE SEQRES 27 A 387 VAL LEU VAL GLY GLY SER THR ARG ILE PRO LYS ILE GLN SEQRES 28 A 387 LYS LEU LEU GLN ASP PHE PHE ASN GLY LYS GLU LEU ASN SEQRES 29 A 387 LYS SER ILE ASN PRO ASP GLU ALA VAL ALA TYR GLY ALA SEQRES 30 A 387 ALA VAL GLN ALA ALA ILE LEU ILE GLY ASP SEQRES 1 B 387 GLY SER HIS MET ARG GLY PRO ALA ILE GLY ILE ASP LEU SEQRES 2 B 387 GLY THR THR TYR SER CYS VAL GLY VAL PHE GLN HIS GLY SEQRES 3 B 387 LYS VAL GLU ILE ILE ALA ASN ASP GLN GLY ASN ARG THR SEQRES 4 B 387 THR PRO SER TYR VAL ALA PHE THR ASP THR GLU ARG LEU SEQRES 5 B 387 ILE GLY ASP ALA ALA LYS ASN GLN VAL ALA MET ASN PRO SEQRES 6 B 387 THR ASN THR ILE PHE ASP ALA LYS ARG LEU ILE GLY ARG SEQRES 7 B 387 LYS PHE GLU ASP ALA THR VAL GLN SER ASP MET LYS HIS SEQRES 8 B 387 TRP PRO PHE ARG VAL VAL SER GLU GLY GLY LYS PRO LYS SEQRES 9 B 387 VAL GLN VAL GLU TYR LYS GLY GLU THR LYS THR PHE PHE SEQRES 10 B 387 PRO GLU GLU ILE SER SER MET VAL LEU THR LYS MET LYS SEQRES 11 B 387 GLU ILE ALA GLU ALA TYR LEU GLY GLY LYS VAL HIS SER SEQRES 12 B 387 ALA VAL ILE THR VAL PRO ALA TYR PHE ASN ASP SER GLN SEQRES 13 B 387 ARG GLN ALA THR LYS ASP ALA GLY THR ILE THR GLY LEU SEQRES 14 B 387 ASN VAL LEU ARG ILE ILE ASN GLU PRO THR ALA ALA ALA SEQRES 15 B 387 ILE ALA TYR GLY LEU ASP LYS LYS GLY CYS ALA GLY GLY SEQRES 16 B 387 GLU LYS ASN VAL LEU ILE PHE ASP LEU GLY GLY GLY THR SEQRES 17 B 387 PHE ASP VAL SER ILE LEU THR ILE GLU ASP GLY ILE PHE SEQRES 18 B 387 GLU VAL LYS SER THR ALA GLY ASP THR HIS LEU GLY GLY SEQRES 19 B 387 GLU ASP PHE ASP ASN ARG MET VAL SER HIS LEU ALA GLU SEQRES 20 B 387 GLU PHE LYS ARG LYS HIS LYS LYS ASP ILE GLY PRO ASN SEQRES 21 B 387 LYS ARG ALA VAL ARG ARG LEU ARG THR ALA CYS GLU ARG SEQRES 22 B 387 ALA LYS ARG THR LEU SER SER SER THR GLN ALA SER ILE SEQRES 23 B 387 GLU ILE ASP SER LEU TYR GLU GLY VAL ASP PHE TYR THR SEQRES 24 B 387 SER ILE THR ARG ALA ARG PHE GLU GLU LEU ASN ALA ASP SEQRES 25 B 387 LEU PHE ARG GLY THR LEU GLU PRO VAL GLU LYS ALA LEU SEQRES 26 B 387 ARG ASP ALA LYS LEU ASP LYS GLY GLN ILE GLN GLU ILE SEQRES 27 B 387 VAL LEU VAL GLY GLY SER THR ARG ILE PRO LYS ILE GLN SEQRES 28 B 387 LYS LEU LEU GLN ASP PHE PHE ASN GLY LYS GLU LEU ASN SEQRES 29 B 387 LYS SER ILE ASN PRO ASP GLU ALA VAL ALA TYR GLY ALA SEQRES 30 B 387 ALA VAL GLN ALA ALA ILE LEU ILE GLY ASP HET PZA A1385 14 HET PZA B1385 14 HETNAM PZA PYRAZINE-2-CARBOXAMIDE HETSYN PZA PYRAZINAMIDE FORMUL 3 PZA 2(C5 H5 N3 O) FORMUL 5 HOH *878(H2 O) HELIX 1 1 GLY A 52 GLN A 58 1 7 HELIX 2 2 ASN A 62 THR A 64 5 3 HELIX 3 3 ASP A 69 LEU A 73 5 5 HELIX 4 4 ASP A 80 LYS A 88 1 9 HELIX 5 5 PHE A 115 GLY A 136 1 22 HELIX 6 6 ASN A 151 GLY A 166 1 16 HELIX 7 7 GLU A 175 TYR A 183 1 9 HELIX 8 8 GLY A 231 LYS A 252 1 22 HELIX 9 9 ASN A 258 LEU A 276 1 19 HELIX 10 10 ARG A 301 ASN A 308 1 8 HELIX 11 11 ASN A 308 GLY A 314 1 7 HELIX 12 12 THR A 315 LYS A 327 1 13 HELIX 13 13 ASP A 329 ILE A 333 5 5 HELIX 14 14 GLY A 340 ARG A 344 5 5 HELIX 15 15 ILE A 345 PHE A 356 1 12 HELIX 16 16 GLU A 369 ILE A 383 1 15 HELIX 17 17 GLY B 52 GLN B 58 1 7 HELIX 18 18 ASN B 62 THR B 64 5 3 HELIX 19 19 ASP B 69 LEU B 73 5 5 HELIX 20 20 ASP B 80 LYS B 88 1 9 HELIX 21 21 PHE B 115 GLY B 136 1 22 HELIX 22 22 ASN B 151 GLY B 166 1 16 HELIX 23 23 GLU B 175 TYR B 183 1 9 HELIX 24 24 GLY B 231 LYS B 252 1 22 HELIX 25 25 ASN B 258 SER B 277 1 20 HELIX 26 26 ARG B 301 ASN B 308 1 8 HELIX 27 27 ASN B 308 GLY B 314 1 7 HELIX 28 28 THR B 315 LYS B 327 1 13 HELIX 29 29 ASP B 329 ILE B 333 5 5 HELIX 30 30 GLY B 340 ARG B 344 5 5 HELIX 31 31 ILE B 345 PHE B 356 1 12 HELIX 32 32 GLU B 369 GLY B 384 1 16 SHEET 1 AA 2 LYS A 25 ILE A 28 0 SHEET 2 AA 2 TYR A 15 GLN A 22 1 O VAL A 20 N GLU A 27 SHEET 1 AB 2 THR A 38 PRO A 39 0 SHEET 2 AB 2 TYR A 15 GLN A 22 -1 O SER A 16 N THR A 38 SHEET 1 AC 5 ASN A 168 ASN A 174 0 SHEET 2 AC 5 SER A 141 VAL A 146 1 O ALA A 142 N LEU A 170 SHEET 3 AC 5 ALA A 6 ASP A 10 1 O ILE A 7 N VAL A 143 SHEET 4 AC 5 TYR A 15 GLN A 22 -1 O CYS A 17 N ASP A 10 SHEET 5 AC 5 LYS A 25 ILE A 28 1 O LYS A 25 N GLN A 22 SHEET 1 AD 5 ASN A 168 ASN A 174 0 SHEET 2 AD 5 SER A 141 VAL A 146 1 O ALA A 142 N LEU A 170 SHEET 3 AD 5 ALA A 6 ASP A 10 1 O ILE A 7 N VAL A 143 SHEET 4 AD 5 TYR A 15 GLN A 22 -1 O CYS A 17 N ASP A 10 SHEET 5 AD 5 THR A 38 PRO A 39 -1 O THR A 38 N SER A 16 SHEET 1 AE 3 ARG A 49 ILE A 51 0 SHEET 2 AE 3 VAL A 42 PHE A 44 -1 O ALA A 43 N LEU A 50 SHEET 3 AE 3 THR A 66 ILE A 67 -1 O ILE A 67 N VAL A 42 SHEET 1 AF 3 ARG A 93 GLU A 97 0 SHEET 2 AF 3 LYS A 100 TYR A 107 -1 O LYS A 100 N GLU A 97 SHEET 3 AF 3 GLU A 110 PHE A 114 -1 O GLU A 110 N TYR A 107 SHEET 1 AG 4 ILE A 218 ASP A 227 0 SHEET 2 AG 4 PHE A 207 GLU A 215 -1 O PHE A 207 N ASP A 227 SHEET 3 AG 4 GLU A 194 LEU A 202 -1 O LYS A 195 N ILE A 214 SHEET 4 AG 4 GLU A 335 VAL A 339 1 O GLU A 335 N LEU A 198 SHEET 1 AH 2 GLN A 281 TYR A 290 0 SHEET 2 AH 2 VAL A 293 THR A 300 -1 O VAL A 293 N LEU A 289 SHEET 1 BA 2 LYS B 25 ILE B 28 0 SHEET 2 BA 2 TYR B 15 GLN B 22 1 O VAL B 20 N GLU B 27 SHEET 1 BB 2 THR B 38 PRO B 39 0 SHEET 2 BB 2 TYR B 15 GLN B 22 -1 O SER B 16 N THR B 38 SHEET 1 BC 5 ASN B 168 ASN B 174 0 SHEET 2 BC 5 SER B 141 VAL B 146 1 O ALA B 142 N LEU B 170 SHEET 3 BC 5 ALA B 6 ASP B 10 1 O ILE B 7 N VAL B 143 SHEET 4 BC 5 TYR B 15 GLN B 22 -1 O CYS B 17 N ASP B 10 SHEET 5 BC 5 LYS B 25 ILE B 28 1 O LYS B 25 N GLN B 22 SHEET 1 BD 5 ASN B 168 ASN B 174 0 SHEET 2 BD 5 SER B 141 VAL B 146 1 O ALA B 142 N LEU B 170 SHEET 3 BD 5 ALA B 6 ASP B 10 1 O ILE B 7 N VAL B 143 SHEET 4 BD 5 TYR B 15 GLN B 22 -1 O CYS B 17 N ASP B 10 SHEET 5 BD 5 THR B 38 PRO B 39 -1 O THR B 38 N SER B 16 SHEET 1 BE 3 ARG B 49 ILE B 51 0 SHEET 2 BE 3 VAL B 42 PHE B 44 -1 O ALA B 43 N LEU B 50 SHEET 3 BE 3 THR B 66 ILE B 67 -1 O ILE B 67 N VAL B 42 SHEET 1 BF 3 ARG B 93 GLU B 97 0 SHEET 2 BF 3 LYS B 100 TYR B 107 -1 O LYS B 100 N GLU B 97 SHEET 3 BF 3 GLU B 110 PHE B 114 -1 O GLU B 110 N TYR B 107 SHEET 1 BG 4 ILE B 218 ASP B 227 0 SHEET 2 BG 4 PHE B 207 GLU B 215 -1 O PHE B 207 N ASP B 227 SHEET 3 BG 4 LYS B 195 LEU B 202 -1 O LYS B 195 N ILE B 214 SHEET 4 BG 4 GLU B 335 VAL B 339 1 O GLU B 335 N LEU B 198 SHEET 1 BH 2 GLN B 281 TYR B 290 0 SHEET 2 BH 2 VAL B 293 THR B 300 -1 O VAL B 293 N LEU B 289 CISPEP 1 GLY A 4 PRO A 5 0 -1.08 CISPEP 2 GLY B 4 PRO B 5 0 -1.56 SITE 1 AC1 6 ASN A 237 VAL A 240 SER A 241 GLY A 256 SITE 2 AC1 6 VAL A 262 ARG A 266 SITE 1 AC2 6 ASN B 237 VAL B 240 SER B 241 GLY B 256 SITE 2 AC2 6 ARG B 266 HOH B2407 CRYST1 48.800 95.062 81.779 90.00 90.03 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020492 0.000000 0.000011 0.00000 SCALE2 0.000000 0.010519 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012228 0.00000 MTRIX1 1 1.000000 0.000250 0.000870 24.37200 1 MTRIX2 1 0.000250 -1.000000 0.001410 -9.22400 1 MTRIX3 1 0.000870 -0.001410 -1.000000 40.84600 1